Contact Person : Barbara Cavilla; Last Date for the submission of abstract : Not Available ; Description : Issues to be addressed in the meeting will include: +How may RNAi techniques identify and validate targets of relevance to cancer therapy? +How might RNAi sequences be developed into commercially and clinically successful therapeutic agen